Evaluate Ltd.

24.06.2013 – 15:02
Return to Growth for Pharmaceutical Sector: Surge in Drug Approvals, R&D Productivity and Investor Confidence to Drive Expansion Through 2018
London And Boston (ots/PRNewswire) - The industry is poised for a healthier turn after sales declined in 2012, says Evaluate's "World Preview 2013, Outlook to 2018" report According to the newly-released World Preview report from market intelligence firm Evaluate Ltd, the worst of the patent cliff is behind us. ...
mehr
27.03.2013 – 17:21
Pharma in 2012: Boom or Bust?
London And Boston (ots/PRNewswire) - EP Vantage(R) [http://www.epvantage.com/default.aspx ], EvaluatePharma(R) [http://www.evaluatepharma.com ]'s award-winning editorial team, today released its "2012 Year in Review [http://www.evaluatepharma.com/epvreview2012 ]" report. Despite numerous ups and downs, the sector exited on a positive note, giving hope that 2013 might be the start of sustained recovery. According to the report, Biotech stocks stormed ahead with the NASDAQ ...
mehr